NextVein was founded on a simple idea. Make Vein Visualization affordable. Vein visualization has become the standard of care for successful IV starts, venipuncture, and vein avoidance for aesthetic injectables.
We are a U.S.-based specialist in Vein Visualization whose mission is to offer you the right tools, at the right price to achieve the Standard of Care in venous access.
We are the first meaningful alternative to expensive vein visualization systems. Our product offers the high-performance vein detection found in market-leading hand-held vein visualization and adds advanced features like multicolor projection. As a hand-held device, the clinician can quickly assess the patient to identify veins. It converts to hands-free with the NextVein wheeled stand, freeing both hands for the procedure. This state-of-the-art stand provides a reliable, long-reach solution for procedures and doubles as storage while re-charging.
Our products are selected to deliver market-leading performance at an affordable price, giving you a rapid return on investment.
Our team invented the hand-held vein visualization category and is the most experienced in the industry. NextVein delivers excellent vein visualization products with excellent service and support.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Long Island, New York, Us
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- https://nextvein.com
- HQ
- Long Island, New York
Nextvein Questions
Nextvein's website is https://nextvein.com
Nextvein's LinkedIn profile is https://www.linkedin.com/company/nextvein
Nextvein has
4 employees.
View email and phone details for 4
employees at Nextvein.
Nextvein's industry is
Medical Equipment Manufacturing
Nextvein's categories are Medical Equipment Manufacturing
Nextvein's founding year is 2021
